Multitargeting nature of muscarinic orthosteric agonists and antagonists

HIGHLIGHTS

• who: . et al. from the University of Aberdeen, United Kingdom have published the article: Multitargeting nature of muscarinic orthosteric agonists and antagonists, in the Journal: (JOURNAL) of 20/06/2022
• what: The authors focus on the multiple-target binding of widely used muscarinic drugs that are usually considered subtype-specific.
• how: The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

SUMMARY

Oxotremorine, which is usually considered M1-selective, activates all muscarinic . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.